Chronic kidney disease. Chronic kidney disease
Conditions
Interventions
Intervention 1: Intervention Group: taking probiotics capsule (4BioCap 180 mg) made by Tehran Daroo company Containing: Lactobacillus acidophilus, Bifidobacterium SPP, Streptococcus thermophilus, Lact
Sponsors
Shahroud University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: over 18 years of age, glomerular filtration rate less than 15 ml/min, having routine diets
Exclusion criteria
Exclusion criteria: infectious diseases, pregnancy (for female participants), autoimmune or immunosuppressive diseases, taking immunosuppressive drugs or antibiotics, lactose intolerance
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum level of endotoxin. Timepoint: Before and after the intervention (6 months). Method of measurement: Limulus Amebocyte Lysate (LAL) kit.;DNA Damage of peripheral blood mononuclear lymphocytes. Timepoint: Before and after the intervention (6 months). Method of measurement: Comet Assay.;Faecel level of endotoixn. Timepoint: Before and after the intervention (6 months). Method of measurement: Limulus Amebocyte Lysate (LAL) kit. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAlireza Jafar
Shahroud University of Medical Sciences
Outcome results
None listed